knowledge -WSS

knowledge

author：hotspot 2025-09-30 16:25:56 - browse：76

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Insmed lung disease drug hits target in key Phase 3 trial

WSS

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

NIH nominee Bertagnolli will get October confirmation hearing

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

AstraZeneca chief proposes a novel edit to the drug pricing bill

iTeos Therapeutics debuts first data on TIGIT

What will save rural psychiatry services? Higher Medicaid payments

hotspot

knowledge

hotspot

In Memoriam: Notable people who died in 2023

Startling documents reveal new facets of Sacklers' opioid empire

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What drug price negotiations mean for Medicare Part D

BioMarin wins approval for gene therapy to treat hemophilia A

What American doctors can learn from their Israeli counterparts

Medicare details structure of new drug price negotiation program

Amazon on where the company's health care bets are headed next

Novavax promises a turnaround & Lilly roils the obesity market

'Make People Better': The CRISPR babies story you probably don't know

leisure time

Stigma and the return of syphilis

A new House health package & hospitals’ new site

Stem cell treatment guidelines are released by FDA

Health insurers say they are turning to AI to cut costs, improve care

Why Novartis is changing the name of its research labs

Startling documents reveal new facets of Sacklers' opioid empire

hotspot

entertainment

leisure time

Wikipedia